NasdaqCM - Delayed Quote USD
Aprea Therapeutics, Inc. (APRE)
1.8100
+0.0700
+(4.02%)
At close: 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-13,556.7180
-13,556.7180
-12,177.6080
-25,011.1360
-37,686.1790
Investing Cash Flow
-15.4780
-15.4780
-93.0930
--
--
Financing Cash Flow
14,821.8950
14,821.8950
5,139.9900
682.9730
1,747.0120
End Cash Position
22,890.0550
22,890.0550
21,647.5370
28,786.6470
53,076.0520
Capital Expenditure
-15.4780
-15.4780
-93.0930
--
--
Issuance of Capital Stock
16,140.3560
16,140.3560
5,788.9180
682.9730
1,538.6450
Free Cash Flow
-13,572.1960
-13,572.1960
-12,270.7010
-25,011.1360
-37,686.1790
12/31/2021 - 10/3/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTL Artelo Biosciences, Inc.
1.0100
+3.06%
CMMB Chemomab Therapeutics Ltd.
1.3700
+1.48%
COGT Cogent Biosciences, Inc.
5.63
+8.06%
AIMI AIM ImmunoTech Inc.
0.0799
+7.25%
CYCN Cyclerion Therapeutics, Inc.
3.3000
-4.35%
IKNA Ikena Oncology, Inc.
1.2200
-3.94%
TRDA Entrada Therapeutics, Inc.
9.05
-0.88%
CALC CalciMedica, Inc.
1.5500
-1.27%
GNTA Genenta Science S.p.A.
3.9700
-1.98%
ADAG Adagene Inc.
1.5800
+3.95%